Klaria Pharma Valuation
| KLAR Stock | SEK 0.42 0.03 6.67% |
Klaria Pharma is fairly valued. Klaria Pharma Holding secures a last-minute Real Value of kr0.44 per share. The latest price of the firm is kr0.42. Our model forecasts the value of Klaria Pharma Holding from analyzing the firm fundamentals such as Shares Outstanding of 63.1 M, return on equity of -0.88, and Operating Margin of (9.48) % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Klaria Pharma's price fluctuation is out of control at this time. Calculation of the real value of Klaria Pharma Holding is based on 3 months time horizon. Increasing Klaria Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Klaria Pharma's intrinsic value may or may not be the same as its current market price of 0.42, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.42 | Real 0.44 | Hype 0.45 | Naive 0.56 |
The intrinsic value of Klaria Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Klaria Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Klaria Pharma Holding helps investors to forecast how Klaria stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Klaria Pharma more accurately as focusing exclusively on Klaria Pharma's fundamentals will not take into account other important factors: Klaria Pharma Total Value Analysis
Klaria Pharma Holding is now anticipated to have takeover price of 88.14 M with market capitalization of 39.49 M, debt of 1.02 M, and cash on hands of 25.49 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Klaria Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
88.14 M | 39.49 M | 1.02 M | 25.49 M |
Klaria Pharma Asset Utilization
One of the ways to look at asset utilization of Klaria is to check how much profit was generated for every dollar of assets it reports. Klaria Pharma Holding secures a negative usage of assets of -0.29 %, losing kr0.002915 for each kronor of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each kronor of assets it secures. Strictly speaking, asset utilization of Klaria Pharma Holding shows how discouraging it operates for each kronor spent on its assets.Klaria Pharma Ownership Allocation
Klaria Pharma Holding maintains a total of 63.1 Million outstanding shares. Klaria Pharma Holding secures 10.73 % of its outstanding shares held by insiders and 9.75 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Klaria Pharma Profitability Analysis
Net Loss for the year was (53.53 M) with profit before overhead, payroll, taxes, and interest of 5.87 M.About Klaria Pharma Valuation
The stock valuation mechanism determines Klaria Pharma's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Klaria Pharma Holding based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Klaria Pharma. We calculate exposure to Klaria Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Klaria Pharma's related companies.Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct Klaria Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Klaria Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Klaria Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Klaria Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Klaria Pharma's revenue streams: Identify Klaria Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Klaria Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Klaria Pharma's growth potential: Evaluate Klaria Pharma's management, business model, and growth potential.
- Determine Klaria Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Klaria Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.